ArticleBMC cancer2020

Real-world patient-reported outcomes of women receiving initial endocrine-based therapy for HR+/HER2- advanced breast cancer in five European countries.

Alison Davie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.